Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
The company has 3 R&D and 5 manufacturing facilities.
Financial Results:
Alembic Pharmaceuticals Ltd reported Revenues for Q2FY24 of ₹1,595.00 Crores up from ₹1,475.00 Crore year on year, a rise of 8.14%.
Total Expenses for Q2FY24 of ₹1,471.00 Crores up from ₹1,324.00 Crores year on year, a rise of 11.1%.
Consolidated Net Profit of ₹137.00 Crores up 3.01% from ₹133.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹6.95, up 2.51% from ₹6.78 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.